PMDA device listing
ケミルミ 抗TPO抗体II（第1版）(アテリカ用)
PMDA In vitro diagnostic listing · 13E1X80031000082 · Class I
Key facts
| PMDA document key | 341508_13E1X80031000082_B_01 |
|---|---|
| Brand names | ケミルミ 抗TPO抗体II（第1版）(アテリカ用) |
| General names (JMDN) | 血液検査用甲状腺ペルオキシダーゼ抗体キット |
| Product type | In vitro diagnostic |
| Device class (Japan) | Class I |
| Approval, certification or notification number | 13E1X80031000082 |
| JMDN codes | 30317001 |
| Category code | A0100 |
| Marketing authorization holder | 製造販売／シーメンスヘルスケア・ダイアグノスティクス株式会社 |
| Package insert date | Mar 20, 2025 |
| Latest revision | 2024-12 |
| PMDA product page | pmda.go.jp |
| Package insert on pmda.go.jp | pmda.go.jp |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- Listed Listed on the PMDA site
- No Refers to a technical manual
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA medical device and IVD listings (Japan)
Medical devices and in vitro diagnostics sold in Japan are approved by the MHLW, certified by a registered certification body or notified, depending on class, and the PMDA publishes each product's package insert. Only identifiers, names and dates are shown here; package insert text and review reports are not reproduced.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, medical device package insert database · Source date: